Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy
Clinical trial NCT00144131 · COMPLETED
Trial details
- NCT number
- NCT00144131
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.